IMPACT (Improving Plasma Collection) Clinical Trial

Completed · Not applicable

Conditions studied: Apheresis Related Hypotension

In brief

Prospective, multi-center, randomized, controlled clinical trial to study the safety and effectiveness of a novel plasma collection system software.

Key facts

Study ID

NCT04320823

Run by

Haemonetics Corporation

People needed

3443

Starts

2020-01-06

Expected to finish

2020-04-27

Last updated by the study team

2021-04-09

Who can join

Age: 18 and older, up to 66. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Donors must be qualified to donate plasma per individual site's screening procedures which are in compliance with IQPP standards. If donors do not meet inclusion criteria at subsequent donations but have already been enrolled in the clinical trial, they are eligible to remain in the clinical trial and to donate plasma within the clinical trial once they meet eligibility criteria again, except if they fulfill any of the exclusion criteria listed below.

You may not qualify if…

• All subjects meeting any of the exclusion criteria listed below will be permanently excluded from the clinical trial.
• Subject not able or willing to give consent to participate in the clinical trial.
• Subject donated plasma outside of the present clinical trial after enrolling in this clinical trial.
• Subjects are withdrawn from the clinical trial due to safety concerns by the qualified healthcare providers.
• In addition, all donors for whom a BMI for use in the PPN feature cannot be reliably calculated will be excluded

Where it is running

• Octapharma Plasma — Wichita, Kansas, United States
• Octapharma Plasma — Charlotte, North Carolina, United States
• Octapharma Plasma — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.